1 The eects of I Ks block by chromanol 293B and L-735,821 on rabbit QT-interval, action potential duration (APD), and membrane current were compared to those of E-4031, a recognized I Kr blocker. Measurements were made in rabbit Langendor-perfused whole hearts, isolated papillary muscle, and single isolated ventricular myocytes. 2 Neither chromanol 293B (10 mM) nor L-735,821 (100 nM) had a signi®cant eect on QTc interval in Langendor-perfused hearts. E-4031 (100 nM), on the other hand, signi®cantly increased QTc interval (35.6+3.9%, n=8, P50.05).
Introduction
Pharmacological lengthening of cardiac action potential duration (APD) is a well-recognized means of cardiac arrhythmia suppression (Singh & Vaughan Williams, 1970; Singh, 1988) . Pharmacologic agents that target the membrane current recognized as most responsible for initiation of ®nal action potential repolarization have therefore been intensely sought and developed over the past two decades as new antiarrhythmic agents. This current, the outwardly directed delayed recti®er potassium current (I K ) in most species (Noble & Tsien, 1969; Sanguinetti & Jurkiewicz, 1990; Follmer & Colatsky, 1990; VarroÂ et al., 1993; Gintant, 1996; Salata et al., 1996b) including man (Li et al., 1996; Iost et al., 1998; consists of both a rapid (I Kr ) and slow (I Ks ) component. The two components of I K dier from each other in terms of their drug sensitivity, current recti®cation, and kinetics (Sanguinettishort ones. Thus, when the time between initiation of successive action potentials is short and an APD increase is expected to provide the most antiarrhythmic bene®t, the actual APD increase is least. Conversely, when the time between successive action potentials is long, I Kr block produces a far greater increase in APD. Long APDs due to block of I Kr at long diastolic intervals and slow heart rates are associated with induction of early after depolarizations believed to trigger Torsade de Pointes ventricular arrhythmias (Hohnloser & Woosley, 1994) .
Selective I Ks block, on the other hand, is hypothesized to increase APD and refractoriness in a frequency-independent manner (Jurkiewicz & Sanguinetti, 1993) . Because of this, the search for selective I Ks blockers has intensi®ed as they may represent novel antiarrhythmic agents devoid of the risk of Torsade de Pointes arrhythmia induction. Propofol, thiopenthone (Heath & Terrar, 1996a) and indapamide (Turgeon et al., 1994) were ®rst recognized as I Ks blockers in guinea-pig ventricular myocytes. However, both these agents require concentrations greater than 100 mM to produce I Ks block so that concerns over their selectivity and possible therapeutic usefulness have been justi®ably raised. Three newer compounds, chromanol 293B (Busch et al., 1996; VarroÂ et al., 2000) , L-735,821 (Salata et al., 1996a; Cordeiro et al., 1998; VarroÂ et al., 2000) and L-768,673 (Selnick et al., 1997; Lynch et al., 1999) have recently been reported to selectively block I Ks . The eects of these compounds on QTc and cardiac action potential con®guration, however, have not been characterized in rabbit, which represents a species widely used to determine the eects of new antiarrhythmic agents intended for use in man. Available published results of describing chromanol 293B and L-735821 eects, in fact, have often contradicted each other (e.g., Schreieck et al., 1997; Cordeiro et al., 1998; Anyukhovsky et al., 1999; VarroÂ et al., 2000) . These contradictory ®ndings have caused us to question whether these dierences may be due to species and regional variations in I Ks (VarroÂ et al., 2000) .
Therefore, the major objective of this study was to characterize the eects of chromanol 293B and L-735,821 on whole heart QTc, papillary muscle APD, and isolated myocyte membrane current in rabbit; a species widely used for antiarrhythmic drug testing. For comparison, we compared the eects of the two I Ks blockers to those of E-4031, a recognized I Kr blocker.
Methods
All experiments were conducted in compliance with the Guide for the Care and Use of Laboratory Animals (U.S. A. NIH publication No 85-23, revised 1985) . The protocols were approved by the review board of Committee on Animal Research of the Albert Szent-GyoÈ rgyi Medical University (54/1999 OEj).
Preparation of the rabbit heart
New Zealand rabbits weighing 1.5 ± 2.0 kg of either sex were used. Each animal was sacri®ced by cervical dislocation after an intravenous injection of 400 IU kg 71 heparin. The chest was opened, the heart quickly removed and immediately immersed in oxygenated modi®ed Locke's solution containing (in mM): NaCl 120, KCl 4, CaCl 2 1.0, MgCl 2 1, NaHCO 3 22 and glucose 11. This solution had a pH ranging between 7.35 and 7.45 when saturated with 95% O 2 and 5% CO 2 at 378C.
ECG measurements in Langendorff-perfused rabbit hearts
The hearts were after removal mounted on a modi®ed, 60 cm high Langendor column and perfused with oxygenated modi®ed Locke's solution warmed to 378C. After¯ushing blood from the coronary vasculature for 3 ± 5 min, the heart was immersed in a tissue chamber ®lled with perfusion solution maintained at 378C while continuing perfusion.
Volume-conducted electrocardiograms (ECGs) were obtained as previously described (Zabel et al., 1995) . Brie¯y, four silver-silver chloride electrodes were positioned in a simulated Einthoven con®guration with the reference and foot' electrodes situated beneath the heart and the`arm' electrodes ®xed to the upper walls of the tissue chamber to record the six bipolar ECG leads I through aVF. All leads were acquired by an ECG signal processing system (Cardiax 2.46, IMED Ltd., Budapest, Hungary) utilizing a 486-microprocessor based, IBM compatible personal computer. After analogue-to-digital conversion, the data were stored to hard disk and analysed o-line. Illustrated ECGs are displayed at 50 mm s
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. After an 1 h equilibration period, baseline ECGs were obtained and a 40 min perfusion period was initiated with either chromanol 293B, L-735,821 or E-4031. ECG recordings were monitored continuously and compared to baseline measurements at the end of this period. QT intervals were always measured on lead II from QRS onset to the end of the T wave; biphasic T waves were measured to the time of ®nal baseline return. These QT measurements and simultaneously recorded RR intervals were used to derive heart rate corrected QT intervals using Carlsson's formula (QTc=QT 70.175 (RR-300)) (Carlsson et al., 1993) . ECG parameters were averaged from measures of three consecutive complexes and a single observer performed all analyses.
Conventional microelectrode measurements
Isolated right ventricular papillary muscle preparations were mounted individually in a tissue chamber (volume *40 ml) continuously superfused with modi®ed Locke's solution warmed to 378C while stimulated (Hugo Sachs Elektronik Stimulator Type 215/II, March-Hugstetten, Germany) at an 1000 ms constant cycle length (frequency=1 Hz) using rectangular constant current pulses 2 ms in duration. These stimuli were isolated from ground and delivered through a bipolar platinum electrode in contact with the preparation. At least 1 h was allowed for each preparation to equilibrate after mounting before experimental measurements were initiated.
Transmembrane potentials were recorded using conventional 5 ± 20 Mohm, 3 M KCl ®lled microelectrodes connected to the input of a high impedance electrometer (Biologic Ampli®er VF 102, Claix, France). In addition, the ®rst derivative of transmembrane voltage with respect to time (V max ) was electronically derived (Biologic Dierentiator DV 140, Claix, France) and with transmembrane voltage continuously monitored on a dual beam storage oscilloscope (Tektronix 2230, 100 MHz Digital Storage Oscilloscope).
The maximum diastolic potential (MDP), action potential amplitude (APA) and action potential durations at 50 and 90% of repolarization (APD 50 and APD 90 ) were automatically measured using software developed in our laboratory (Hugo Sachs Elektronik, Action Potential Evaluation System (APES)) running on a 386-microprocessor based, IBM compatible computer containing an ADA 3300 analogue-todigital data acquisition board (Real Time Devices Inc.; State College, PA, U.S.A.) with a maximum sampling frequency of 40 KHz. In each experiment, baseline action potential characteristics were ®rst determined during continuous pacing at 1 Hz, and then while pacing cycle length was sequentially varied between 300 and 5000 ms. Twenty-®ve action potential were evoked at each cycle length and the cycle length was then changed so that`quasi' steady-state frequency response relations could be rapidly generated. Each preparation was then superfused for 40 ± 60 min with either chromanol 293B (Hoechst AG, Frankfurt, Germany), L-735,821 (MerckSharpe & Dohme Laboratories, West Point, PA, U.S.A.) or E-4031 (Institute for Drug Research, Budapest, Hungary) before repeating the pacing protocol. Attempts were made to maintain the same impalement throughout each experiment. If, however, an impalement became dislodged, adjustments were attempted, and if the action potential characteristics of the re-established impalement deviated by less than 5% from the previous measurement the experiment continued. When this arbitrary 5% limit was exceeded, the experiment was terminated and all data obtained excluded from analyses.
Patch-clamp measurements
Cell isolation Single ventricular myocytes were obtained by enzymatic dissociation of isolated New Zealand rabbit hearts. The chest was opened and the heart quickly removed and placed into cold (48C) solution with the following composition (mM): NaCl 135, KCl 4.7, KH 2 PO 4 1.2, MgSO 4 1.2, HEPES 10, NaHCO 3 4.4, Glucose 10, CaCl 2 1.8, (pH 7.2). The heart was then mounted on a modi®ed, 60 cm high Langendor column and perfused with oxygenated perfusate of the same composition warmed to 378C. After 3 ± 5 min of perfusion to¯ush blood from the coronary vasculature, the perfusate was switched to one having no exogenously added calcium (i.e., to one that was nominally Ca 2+ -free) until the heart ceased contracting (*3 74 min). Enzymatic digestion was accomplished by perfusion with the same, nominally Ca 2+ -free solution with 0.33 mg ml 71 (90 U ml
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) Collagenase (Sigma Type 1) and 0.02 mg ml
71 Pronase E (Sigma) in 0.1% Albumin added. Perfusion rate was maintained constant using a perfusion pump (¯ow rate *15 ml min 71 ). After 15 min of the enzymatic perfusion, calcium was elevated to a concentration of 200 mM. Thirty to 35 minutes later the heart was removed from the aortic cannula and placed into enzyme free solution containing 1.8 mM CaCl 2 and 1% albumin warmed to 378C for 10 min. Then, the tissue was minced into small chunks, and following gentle agitation myocytes were separated by ®ltering the resulting slurry through a nylon mesh. Myocytes were ®nally harvested by gravity sedimentation. Once the majority of individual myocytes had settled to the bottom of the container, the supernatant was decanted and replaced with Tyrode solution containing 1.8 mM CaCl 2 and the myocytes resuspended by gentle agitation. This procedure was repeated twice more and the resulting myocyte suspension was stored in HEPES buered Tyrode solution at 10 ± 148C.
Experimental procedure, drugs and solutions One drop of cell suspension was placed in a transparent recording chamber mounted on the stage of an inverted microscope (TMS; Nikon, Tokyo, Japan) and at least 5 min were allowed for individual myocytes to settle and adhere to the chamber bottom before initiating superfusion. Myocytes were used that were rod shaped with clear striations. HEPES buered Tyrode solution served as the normal superfusate in all experiments. This solution contained (mM): NaCl 144, NaH 2 PO 4 0.33, KCl 4.0, CaCl 2 1.8, MgCl 2 0.53, Glucose 5.5, and HEPES 5.0 at pH 7.4.
Patch-clamp micropipettes were fabricated from borosilicate glass capillaries (Clark, Reading, U.K.) using a P-97 Flaming/Brown micropipette puller (Sutter Instrument Co, Novato, CA, U.S.A.). These electrodes had resistances between 1.5 and 2.5 Mohm when ®lled with pipette solution containing (in mM): K-aspartate 100, KCl 45, K 2 ATP 3, MgCl 2 1, EGTA 10, and HEPES 5. The pH of this solution was adjusted to 7.2 by addition of KOH. Nisoldipine (1 mM) (Bayer AG, Leverkusen, Germany) in the external solution eliminated inward Ca 2+ current (I Ca ) while the sodium current (I Na ) was inactivated during experiments by applying a holding potential of 740 mV. At this holding potential, transient outward current (I to ) was also largely inactivated. An Axopatch-1D ampli®er (Axon Instruments, Foster City, CA, U.S.A.) was used to record membrane current in the whole-cell con®guration of the patch-clamp technique. After establishing a high (1 ± 10 Gohm) resistance seal by gentle suction, the cell membrane beneath the tip of the electrode was disrupted by further suction or application of 1.5 V electrical pulses applied for 1 ± 5 ms. Cell capacitance (150.14+0.14 pF, n=73) was measured by applying a 10 mV hyperpolarizing pulse from a holding potential of 710 mV and integration of the capacitive transient over time divided by the amplitude of the voltage step (10 mV). Series resistance was typically 4 ± 8 Mohm prior to compensation (50 ± 80%, depending on the voltage protocol utilized). Experiments where the series resistance was high, or where it increased substantially during measurement, were terminated and the data discarded. Membrane currents were digitized using a 333 kHz analogue-to-digital converter (Digidata 1200, Axon Instruments, with sampling rate ranging 0.4 ± 50 kHz) under software control (pClamp 6.0, Axon Instruments). Analyses were performed using Axon (pClamp 6.0) software after low-pass ®ltering at 1 kHz. All patch-clamp data were collected at 378C.
Solutions and the choice of drug concentrations Chromanol 293B was diluted at the time of use from a 10 mM stock solution containing 100% DMSO. DMSO at the resulting concentrations (0.1 ± 0.3%) produced no discernible eect on QTc, APD, or the membrane currents assessed. L-735,821 was diluted from a 100 mM stock solution containing 10% DMSO. All stock solutions were prepared using HEPES buered Tyrode solution as the solvent. E-4031 was diluted from a 1 mM aqueous stock solution at the time of each experiment. The concentrations of L-735,821 (100 nM) and chromanol 293B (10 mM) were comparable to those used by others and shown to block I Ks in other species (Salata et al., 1996a; Busch et al., 1996; VarroÂ et al., 2000) . We used 100 nM L-735,821 to assure completely block I Ks during assessment of I Kn and 1 ± 5 mM E-4031 to fully block I Kr during assessment of I Ks . E-4031 concentrations were also similar to those used previously by us and others (Sanguinetti & Jurkiewicz, 1990; Salata et al., 1996b; Busch et al., 1996; VarroÂ et al., 2000) .
Statistical analyses
Results were compared using Student's t-tests for paired and unpaired data. When P50.05, results were considered signi®cant. Data are expressed as mean+s.e.mean.
Results
Comparison of the effects of I Ks and I Kr block on QTc interval in isolated Langendorff-perfused rabbit hearts
Neither I Ks blocker, chromanol 293B (10 mM) nor L-735,821 (100 nM) signi®cantly lengthened QTc or increased RR interval after 40 min of exposure in isolated, Langendorperfused rabbit hearts after 40 min of exposure ( Figure 1A , B, Table 1 ). The I Kr blocker E-4031 (100 nM), signi®cantly increased QTc under identical conditions ( Figure 1C , Table  1 ). This E-4031 induced increase in QTc was associated with a signi®cant increase in RR interval (420.5+17.5 ms at baseline versus 463.5+17.8 ms after E-4031, n=8, P50.05).
Effects of I Ks and I Kr block on ventricular action potential duration in isolated rabbit papillary muscle Concentrations of chromanol 293B (10 mM) and L-735,821 (100 nM) reported to block I Ks in other species failed to signi®cantly aect rabbit papillary muscle APD while pacing at a constant pacing cycle length of 1000 ms (Figure 2A ,B, Table 2 ). On the other hand, E-4031 (100 nM) markedly and signi®cantly increased rabbit papillary muscle APD under identical conditions after 40 min of exposure ( Figure 2C , Table 2 ). A similar dierence in the eects of chromanol 293B (10 mM) and L-735,821 (100 nM) compared to E-4031 (100 nM) on APD were observed in rabbit ventricular muscle over a wide range of pacing cycle lengths (300 ± 5000 ms) (Figure 3) . Again, chromanol 293B and L-735,821 produced only small changes in APD over this entire range of pacing rates while E-4031 markedly lengthened rabbit papillary muscle APD in a reverse frequency-dependent fashion so that the increase in APD was greater at long cycle lengths than at short ones (Figure 3) . 
Effect of I Ks block in the presence of forskolin
Because I Ks is modulated by changes in intracellular cyclic AMP, we also examined the eect of I Ks block on APD in the presence of 1 mM forskolin to activate adenylcyclase and thereby increase intracellular cyclic AMP. Forskolin (1 mM) alone shortened APD in rabbit papillary muscle paced at cycle length of 1000 ms from 217.4+18.7 to 194.0+15.7 ms (n=5, P50.05, Figure 4A ). Addition of 10 mM chromanol 293B in the continuous presence of forskolin had little eect on APD (194.0+15.7 versus 190.8+12.9 ms, n=5, Figure  4A ). Similar result was obtained with L-735,821 (100 nM, Figure 4B ). These results show that selective I Ks block does not alter APD substantially even in the presence of elevated intracellular cyclic AMP.
Effects of L-735,821 on I Ks compared to that of E-4031 on I Kr in isolated rabbit ventricular myocytes
The eects of L-735,821 (100 nM) on I Ks tail currents following 5000 ms long test pulses to between 0 and +50 mV from and return to a holding potential of 740 mV in the presence of 1 ± 5 mM E-4031 to inhibit I Kr in isolated rabbit ventricular are illustrated in Figure 5A . As illustrated, L-735,821 (100 nM) completely abolished I Ks ( Figure 5A ). In comparison, a greater concentration of E-4031 (1 mM) than used in examining its eects on rabbit QTc and APD was required to fully block I Kr tails currents ( Figure 5B ). In these experiments, eects of E-4031 on I Kr were examined in isolated rabbit ventricular myocytes using 1000 ms test pulses to between 720 and +50 mV from a holding potential of 740 mV (illustrated in the inset of Figure 5B ).
I Ks and I Kr activation and deactivation kinetics in rabbit ventricular myocytes
We recently reported that in dog ventricular myocytes I Kr activates rapidly during depolarizations to positive potentials but deactivates slowly (VarroÂ et al., 2000) . We also found I Ks Figure 3 Frequency dependent eect of the I Ks blockers chromanol 293B (10 mM, n=7) and L-735,821 (100 nM, n=7) on the action potential duration measured at 90% repolarization (APD 90 ) compared to that of the I Kr blocker E-4031 (100 nM, n=8) in isolated rabbit ventricular papillary muscles. E-4031, the I Kr blocker, lengthened APD in a reverse-frequency dependent manner while the two I Ks blockers had little eect. On the abscissa CL=pacing cycle length in ms, and on the ordinate percentile change in APD 90 is given. Bars represent+s.e.mean. I Ks was assessed by measuring peak outward tail current densities following a 5000 ms test pulses to between 720 and +50 mV from a holding potential of 740 mV in seven myocytes in the presence of E-4031 (5 mM) to totally block I Kr . Pulse frequency was 0.1 Hz. Similarly, I Kr was assessed by measuring peak outward tail current densities following a 1000 ms test pulses to between 720 and +50 mV from a holding potential of 740 mV in 10 myocytes in the presence of 100 nM L-735,821 to block I Ks . Pulse frequency was 0.05 Hz. In all studies nisoldipine (1 mM) was used to block inward calcium current (I Ca ). Bars represent+s.e.mean.
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I Ks block fails to lengthen QTc and APD in rabbit C. Lengyel et alto activate slowly at positive potentials in dog ventricular myocytes while it deactivates rapidly with respect to diastolic intervals encountered during physiologic heart rates. We speculated that in dog I Kr and I Ks kinetics such as these likely account for the unremarkable eect of both chromanol 293B and L-735,821 on ventricular muscle (and Purkinje strand) (VarroÂ et al., 2000) . Thus, we wished to determine and compare the kinetics of I Kr and I Ks activation and deactivation in rabbit ventricular myocytes during depolarization to +30 mV; a membrane voltage corresponding roughly to the rabbit ventricular muscle action potential plateau amplitude.
I Ks kinetics were assessed in 22 rabbit ventricular myocytes using an envelope of tails protocol ( Figure 6A ) in the presence of 5 mM E-4031 to eliminate I Kr . Under these conditions, I Ks activation was slow (t=888.1+48.2 ms, n=21, at +30 mV) and I Ks deactivation was fast (t=157.1+4.7 ms, n=22, at 740 mV).
Similarly, using incremental increases in test pulse duration while clamping the membrane potential to +30 mV from a holding potential of 740 mV in an envelope of tails protocol ( Figure 6B ) in the presence of 100 nM L-735,821 to block I Ks , the activation time constant (t) for I Kr was 35.5+3.1 ms (n=26) and deactivation was slow and best ®t as the sum of two exponentials; t 1 =641.5+25.0 ms and t 2 =6531+343 ms with amplitudes of A 1 =32.8+1.7 pA and A 2 =42.4+2.1 pA, respectively (n=35).
To estimate the relative magnitude of I Ks and I Kr activated during rabbit ventricular action potential depolarizations, we compared the amplitudes of the L-735,821 sensitive (I Ks ) and E-4031 sensitive (I Kr ) currents at the end of an 150 ms long test pulse to +30 mV and their tail currents on return to a 740 mV holding potential. The +30 mV corresponds to a membrane voltage slightly more positive to that attained during the plateau of a normal action potential (Figure 2 ). The 740 mV was selected to represent a voltage level encounted during ®nal action potential repolarization (phase III). I Ks and I Kr were measure by subtracting membrane currents before and after 4 ± 5 min of exposure to L 735,821 and E-4031, respectively. The E-4031 sensitive current (I Kr ) amplitude at the end of the 150 ms long test pulse was 34.1+4.2 pA (n=14), or about 30% of the tail current amplitude measured after the voltage test pulse on returned to 740 mV (85.8+9.2 pA, n=14) ( Figure 7A,C) . The L-735,821 sensitive current (I Ks ) during the test pulse to +30 mV was larger than its tail current on return to 740 mV ( Figure 7B,C) . The magnitude of I Ks during the test pulse was 13.27+1.2 pA at +30 mV versus 6.6+0.8 pA at 740 mV, (n=15), approximately an order of magnitude less than the I Kr tail current.
Discussion
Because the surface electrocardiogram remains the best clinical means of assessing antiarrhythmic drug therapy and monitoring development of proarrhythmic side eects, we determined the eects of two new, potentially bene®cial antiarrhythmic agents, chromanol 293B and L-735,821, on QTc in isolated, Langendor-perfused rabbit hearts. This experimental preparation allowed us to also determine the eect of the exact same drug concentrations on rabbit ventricular papillary muscle action potential con®guration as well as the underlying membrane currents in isolated rabbit ventricular myocytes. We also compared the eects of these two reportedly selective I Ks blockers to those of a recognized selective I Kr blocker, E-4031. This comparison allowed direct assessment of the degree of QTc and action potential lengthening produced by complete, selective block of I Ks versus I Kr block in rabbit ventricular tissue. We found that chromanol 293B and L-735,821 did not substantially increase QTc in Langendor-perfused rabbit hearts, nor did they increase isolated rabbit ventricular papillary muscle APD. L-735,821, however, did completely block I Ks in isolated rabbit ventricular myocytes. In contrast, a concentration of E-4031 an order of magnitude less that which totally blocked I Kr markedly increased QTc and rabbit ventricular muscle APD. Thus, if the basis of the ventricular antiarrhythmic eectiveness of I Kr block by agents like E- Figure 6 Activation and deactivation kinetics for I Ks (A) and I Kr (B) in rabbit ventricular myocytes. Activation kinetics (left) measured as peak tail currents at 740 mV after test pulses from a holding potential of 740 to +30 mV with sequentially increasing durations between 10 and 5000 ms. Deactivation kinetics (right) measured from outward tail current upon return to 740 mV after test pulse to +30 mV lasting for 5000 ms with I Ks or for 1000 ms with I Kr . Figure 7 Membrane currents in rabbit ventricular myocytes observed during and after a 150 ms depolarizing pulse to +30 mV from a holding potential of 740 mV before and after I Kr (1 mM E-4031, A) and I Ks (100 nM L-735,821, B) block. (C) Bar graph shows mean+s.e.mean dierence current magnitudes developed during depolarization to +30 mV and peak tail current on return to 740 mV after I Kr (left) and I Ks (right) block.
4031 is cardiac APD prolongation re¯ected as an increase in QTc, selective I Ks block is unlikely to prove to be of antiarrhythmic bene®t. Because the present studies were performed using normal rabbit hearts and recent reports do indicate antiarrhythmic bene®t in vivo following I Ks block (Billman et al., 1998a,b; Lynch et al., 1999) further electrophysiological studies are required to determine how pathophysiological situations may aect selective I Ks block on QTc and APD.
Comparison of the results with earlier findings
Because selective I Ks blockers have only recently become available (Salata et al., 1996a; Busch et al., 1996) relatively few descriptions of their pharmacological eects are yet to be found in the literature. Those studies reporting on the eects of I Ks block on ventricular APD were performed in guinea-pig, dog, and human papillary muscle (Schreieck et al., 1997 , VarroÂ et al., 1999 as well as in isolated guinea-pig, dog, and human ventricular myocytes (Bosch et al., 1998; VarroÂ et al., 2000) . The eects of I Ks block have also been examined in rabbit Purkinje ®ber myocytes (Cordeiro et al., 1998) . These published results at times contradict one another. Schreieck et al. (1997) using conventional microelectrodes, for example, did not observe signi®cant guinea-pig papillary muscle APD increases using 10 mM chromanol 293B. Because I Ks is enhanced by adrenergic stimulation (Bennett & Begenisch, 1987) , some might argue that Schreieck et al 's. failure to induce an increase in APD with chromanol 293B resulted from likely endogenous catecholamine depletion (Schreieck et al., 1997) . Bosch et al. (1998) , on the other hand, reported in both current-clamped guinea-pig and human ventricular myocytes that chromanol 293B increased APD. Only 5 ± 8 myocytes were examined in that study and baseline measurements were not observed in the same myocytes as those exposed to chromanol 293B. Thus, because APD measurements obtained in single, isolated myocytes usually display enormous beat-to-beat variability it is dicult to know how to interpret such results in comparison to other published results using dierent experiment techniques and perhaps better experimental controls. Our present results in isolated rabbit papillary muscles agree with those where Schreieck et al. (1997) found that 10 mM chromanol 293B did not substantially lengthen guinea-pig papillary muscle APD in the absence of forskolin as well as our own results in dog papillary muscle where both chromanol 293B and L-735,821 failed to notably aect APD either in the absence or presence of 1 mM forskolin to increase I Ks in dog ventricle (VarroÂ et al., 2000) . Negligable (less than 5%) QT changes were reported also with L-768,673 in in vivo dog experiments (Lynch et al., 1999) .
Although Cordeiro et al. (1998) found that I Ks block with 20 nM L-735,821 markedly increased APD in isolated rabbit cardiac Purkinje ®bre myocytes, we found no increase in rabbit papillary muscle using 100 nM L-735,821 which totally suppressed I Ks in single ventricular myocytes. We can not provide an explanation for this discrepancy in ®ndings; however, we have previously reported in isolated dog Purkinje strands that L-735,821 produces little eect on APD (VarroÂ et al., 2000) . Thus, it is unlikely that dierences in I Ks expression between ventricular muscle and Purkinje ®bre myocytes explain the dierences between our, and others, results compared to those of Cordeiro et al. (1998) .
Rabbit QTc, papillary muscle APD, and block of I Kr are in excellent agreement with those published by us and others (e.g., Lathrop, 1985; Sanguinetti & Jurkiewicz, 1990; Strauss, et al., 1970; VarroÂ et al., 1985; .
Although we have recently reported (VarroÂ et al., 2000) that I Ks block does not increase dog ventricular muscle APD, one might reasonably argue that because I Ks is relatively weak in dog I Ks block should not be expected to produce much response. Thus, the present ®ndings are important as they extend our previous ®nding to another species, rabbit, where I Ks is usually recorded as a large membrane current relative to other species (Salata et al., 1996b) . In addition, it is important to note that rabbit is a frequently used species in evaluating the eects of new, potentially bene®cial antiarrhythmic drugs. This is likely because in rabbit it is possible to directly compare the eects of equivalent investigational drug concentrations in the entire perfused heart to assess changes in QTc as well as in isolated multicellular papillary muscle and single isolated ventricular myocytes to determine eects on APD and transmembrane current.
Selectivity of I Ks and I Kr block
We intentionally chose to examine concentrations of chromanol 293B and L-735,821 and E-4031 expected to completely or nearly totally block either I Ks or I Kr , respectively. As indicated, the concentration of each drug examined was chosen on the basis of previously published reports of the eects of these compounds on cardiac myocytes membrane currents in other tissues (Cordeiro et al., 1998) and species (Salata et al., 1996b; Schreieck et al., 1997; Bosch et al., 1998) . Our present ®ndings therefore con®rm that 100 nM L-735,821 completely blocked I Ks and that 1 mM E-4031 blocked I Kr in isolated, rabbit ventricular myocytes. This necessary con®rmation of I Ks and I Kr block by L-735,821 and E-4031 also allowed us to examine the kinetics of I Ks and I Kr activation and deactivation in an attempt to provide an explanation for why total I Ks block failed to aect QTc and APD in rabbit ventricle.
Kinetics of I Ks activation and deactivation in rabbit ventricle compared to those of I Kr : implications for prediction of pharmacological effect
We found that in rabbit ventricular myocytes I Ks activated slowly (t=888.1+48.2 ms, n=22) and deactivated rapidly (157.1+4.7, n=22) in relation to the time of normal electrical diastole (193.8+9.8, n=22, calculate from baseline RR intervals ± QT intervals in rabbit heart perfusion experiments) in rabbit ventricle. We also found that I Ks activated rapidly as expected, but deactivated slowly. These ®ndings are in good agreement with our ®ndings in dog ventricle (VarroÂ et al., 2000) where I Ks also produced little eect on QTc and APD in comparison to I Kr block that markedly and signi®cantly lengthened QTc and APD. Gintant originally reported (1996) that in dog ventricular tissue I Ks and I Kr display similar activation and deactivation kinetics that with such kinetics, I Ks accumulation was unlikely at physiologic heart rates. This is unlike the situation in guinea-pig where I Ks deactivates slowly (Jurkiewicz & Sanguinetti, 1993) . Based on the earlier results in guinea-pig ventricular myocytes, selective I Ks block was expected to increase APD without inducing reverse use-dependent lengthening as associated with I Kr block because reduction in outward current due to I Ks block would be greater at short diastolic intervals than at longer times between subsequent action potentials. The important question, therefore, is whether man more closely resembles guinea-pig or dog and rabbit in terms of I Ks and I Kr activation and deactivation kinetics. That is whether it is better to examine new antiarrhythmic drug eects in rabbit and dog ventricular preparation than in guinea-pig prior to initiating clinical studies in man. Our recent report that I Ks deactivates rapidly in human myocytes while I Kr in human myocytes deactivates slowly (Iost et al., 1998; strongly suggests that either rabbit or dog would serve as better preclinical models for examining the eects of new antiarrhythmic agents than guinea-pig, but this question needs further studies, since it is still not satisfactory resolved (Sanguinetti & Jurkiewicz, 1990; Heath & Terrar, 1996a) .
To demonstrate better this relation between I Ks and I Kr in rabbit ventricle, we compared the magnitude of both currents during and at the end of a 150 ms test pulse to +30 mV from a holding potential of 740 mV (inset for Figure 7 ) representing roughly the membrane voltage at the most positive part of the plateau and voltage at the beginning of rabbit ventricular muscle ®nal repolarization. This comparison ( Figure 7) illustrates that when both currents are measured at +30 and 740 mV, I Kr is several times greater than I Ks (2.6 times at +30 mV and 12.9 times at 740 mV, respectively). As such it is not surprising that complete I Ks block had no marked eect on QTc and APD over a wide range of more rapid pacing rates while partial I Kr block markedly and signi®cantly increased both QTc and APD.
These ®ndings explain the failure of I Ks block by chromanol 293B and L-736,821 to substantially increase QTc and APD; however, the hereditary absence of channel proteins responsible for I Ks is associated with the occurrence of one form of inherited Long QT syndrome, LQT1, in man (Keating et al., 1991) . Previously we have addressed this apparent contradiction between the failure of acute pharmacological I Ks block to increase QTc and the clinical ®nding of long QT often associated with hereditary lack of the channels responsible for generation of I Ks (VarroÂ et al., 2000) . We believe that the absence of I Ks in these individuals with LQT1 may hamper their ability to limit excessive APD lengthening due to other causes (e.g. hypokalaemia or bradycardia). This explanation would also help account for ®nding that penetrance (i.e., phenotype divided by genotype) is rather low with LQT1 compared to others forms of LQT (Swan et al., 1998; Priori et al., 1998) .
Another issue not addressed by the studies conducted in this study is the known dierences in anatomic distribution of the channels responsible for expression of I Ks and I Kr . These channels are known to be dierentially distributed between atria and ventricles (Wang et al., 1994; Li et al., 1996) as well as within various regions of the ventricles (Cheng et al., 1999; Volders et al., 1999) . Although we acknowledge that these tissue and regional dierences in I Ks are essential to understand, we only examined the eects of chromanol 293B and L-735,821 in isolated rabbit papillary muscle and ventricular myocytes dispersed from the entire ventricles. As such, we did not seek to examine the eects of these drugs on atrial tissue or whether there are regional dierences in their eects within the ventricles.
Effect of I Ks block in the presence of forskolin
In the present study neither chromanol 293B nor L-735,821 legthened repolarization in the presence of forskolin ( Figure  4) i.e. when intracellular adenylcyclase was stimulated. This result was similar to that found earlier by us in dog (VarroÂ et al., 2000) and dierent by Schreieck et al. (1997) in guineapig papillary muscle who found APD lengthening by 10 mM 293B in the presence of 10 nM isoproterenol. The deviation from the ®ndings of Schreieck et al. (1997) might be due to the species dierences since it is known that in guinea-pig ventricle I Ks amplitude is relatively large compared with other species. Because other currents are also mediated by cyclic AMP (i.e. L-type calcium current (I Ca ), chloride current (I Cl ) and I Kr ) that also signi®cantly aect APD (Walsh et al., 1989; Harvey & Hume, 1989; Heath & Terrar, 2000 ) the observation in the two studies may not be directly due I Ks block alone.
Conclusion
In summary, our results clearly indicate that chromanol 293B and L-735,821 do not increase QTc in Langendor-perfused rabbit hearts, nor do these compounds lengthen rabbit papillary muscle APD, while they do block I Ks in isolated rabbit ventricular myocytes. The kinetics of I Ks and I Kr activation and deactivation in rabbit ventricular myocytes, which are dierent from those reported in guinea-pig and similar to those found in dog and man, serve to explain the results. These new ®ndings suggest that rabbit is a good species for preclinical evaluation of new drugs believed to aect cardiac action potential repolarization.
